Insilico Lands $177M Drug Discovery Deal
Polymarket · x · 2026-07-13
China Medical System has agreed to pay Insilico Medicine up to $177 million to develop treatments for central nervous system diseases.
This AI drug discovery collaboration comes with a clear financial cap, demonstrating the continued commercialization of AI drug discovery in the pharmaceutical industry.
More from Venture
- Beth Kindig says her Q3 AI stocks report flags 5 winners up more than 100% YTD — Beth_Kindig · 2026-07-22
- AI’s economic forecasts are split by nearly a quadrillion dollars by 2035 — bittingthembits · 2026-07-22
- LLM Agent Trader pairs backtesting with model-generated trading signals — tom_doerr · 2026-07-22
- OpenRouter spend data suggests frontier models still capture most paying usage — thedealdirector · 2026-07-21
- AI is collapsing startup and operating costs as U.S. business formation hits a record — sanjaykalra · 2026-07-21
- Soxton lands on investors’ 2026 legal-startup watchlist with $2.5M raised — ashleymayer · 2026-07-21